The Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which harbors numerous mutations at the viral spike protein, evades host immunity by escaping...
In a recent study posted to the bioRxiv* preprint server, researchers identified a nanobody that inhibits severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) variants. Study: Peptide...
In a recent study posted to the medRxiv* preprint server, the researchers assessed immunological and pathophysiological aspects of antenatal coronavirus disease 2019 (COVID-19). Study: Immune...
In a recent study published in the journal Nature, the researchers investigated the impact of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) booster vaccine...
In a recent study published in the Clinical Infectious Diseases journal, the researchers summarized the perspectives and observations on severe acute respiratory syndrome coronavirus 2...
In a recent study published in the Journal of Hepatology, researchers reported that the coronavirus disease 2019 (COVID-19) vaccination could elicit a distinct T cell-dominant...
A COVID-19 vaccine developed at the University of Washington School of Medicine has proven safe and effective in late-stage clinical testing. SK bioscience, the company...
In a recent study posted to the medRxiv* preprint server, researchers assessed the efficacy and safety of monoclonal antibodies (mAbs) for treating severe acute respiratory...
In a recent article posted to the medRxiv* preprint server, researchers assessed the factors influencing the anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) antibodies...
The coronavirus disease 2019 (COVID-19) pandemic broke out early in 2020, following the reporting of several cases of pneumonia caused by the severe acute respiratory...
In a recent study posted to Research Square* preprint server, researchers reported that cross-reactive antibodies against coronaviruses (CoVs) might not cross-neutralize all CoVs. Several studies...
In a recent study posted to the bioRxiv* preprint server, the researchers investigated the impact of Bacillus Calmette-Guérin (BCG) vaccine-induced antibodies against severe acute respiratory...
